BIOA — Bioiasis Balance Sheet
0.000.00%
Annual balance sheet for Bioiasis, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.28 | 0.298 | 0.032 | 0.033 | 0.019 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.015 | 0.013 | 2.62 | 4.34 | 16.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.296 | 0.311 | 3.23 | 5.92 | 18.6 |
| Net Property, Plant And Equipment | — | — | — | 0 | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.297 | 0.311 | 7.85 | 10.7 | 23.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.011 | 0.018 | 2.8 | 5.41 | 3.14 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 0.011 | 0.021 | 7.79 | 10.4 | 23.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 0.286 | 0.289 | 0.056 | 0.246 | 0.164 |
| Total Liabilities & Shareholders' Equity | 0.297 | 0.311 | 7.85 | 10.7 | 23.2 |
| Total Common Shares Outstanding |